First to Patent the Production of Cannabinoid Concentrate

CBD & THC Molecules Ready to Infuse Products in October 2019

What Nextleaf is as a molecule factory. They are the first company to have a patent issued around the production of cannabinoid distillate.  That is their industrial scale process of going from a low grade biomass into that highly refined tasteless, odorless molecule of CBD or THC that then is ready to infuse a variety of products that are legal as of October 2019.

About Nextleaf

Nextleaf pioneers the development and delivery of market-validated, patented cannabis processing solutions. We maximize the return on every harvest, through innovative processes and value-added products.

Nextleaf holds multiple U.S. issued and pending patents for the process of producing cannabinoid distillate, the precursor of every cannabis infused product.

Highly concentrated THC or CBD distillate is odourless, tasteless, and standardized for potency. Nextleaf’s patented process will disrupt the production of infused edibles and beverages.

Nextleaf delivers its proprietary technology at both its Centralized Processing Facility and Mobile Extraction Lab onsite at licensed production facilities.

Through a combination of extraction, refinement and purification steps we create a distillate suitable for a variety of product concepts and methods of consumption.

Our unique approach enables producers and cultivators to bring premium, differentiated products, including consumables and topicals to market safely and efficiently.

For more information on Nextleaf Solutions Ltd. (OILS:CSE) please fill out the form below.

Request Investor Info